Non-vitamin K antagonist oral anti-coagulation agents (NOACs) for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation

Published on 03 May 2017
Last Updated on 06 Feb 2026

Non-vitamin K antagonist oral anticoagulation agents (NOACs) for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation Guidance is outdated and has been withdrawn on 6 February 2026.

NOACs for preventing stroke and systemic embolism in non-valvular atrial fibrillation (Withdrawn 6 Feb 2026) [PDF, 133 KB]

PES Anticoagulants to treat and prevent blood clots (Withdrawn 6 Feb 2026) [PDF, 141 KB]